Table 1 FSHR gene polymorphism at positions 307 and 680 in PCOS, chronic anovulatory, and control women
Position 307 | Position 680 | |||||
|---|---|---|---|---|---|---|
Thr/Thr | Thr/Ala | Ala/Ala | Asn/Asn | Asn/Ser | Ser/Ser | |
PCOS | 52.6% | 39.8% | 7.5% | 51.9% | 44.4% | 3.8% |
(95% CI) (n = 133 women) | (43.8%-61.3%) | (31.6%-48.7%) | (3.9%-13.7%) | (43.1%-60.6%) | (35.8%-53.2%) | (1.4%-9.0%) |
Chronic anovulation | 50.4% | 45.4% | 4.5% | 47.9% | 47.1% | 5.0% |
(95% CI) (n = 121 women) | (42.8%-61.2%) | (34.9%-53.1%) | (1.5% -9.6%) | (40.4%-58.8%) | (36.5%-54.7%) | (2.0%-10.9%) |
Controls | 53.0% | 42.4% | 4.5% | 54.5% | 40.9% | 4.5% |
(95% CI) (n = 132 women) | (44.2%-61.7%) | (34.0%-51.3%) | (1.9%-10.1%) | (45.7%-63.2%) | (32.5%-49.8%) | (1.9%-10.1%) |